Compare RCUS & CXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RCUS | CXT |
|---|---|---|
| Founded | 2015 | 1855 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Office Equipment/Supplies/Services |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 3.0B |
| IPO Year | 2018 | N/A |
| Metric | RCUS | CXT |
|---|---|---|
| Price | $22.78 | $48.03 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 4 |
| Target Price | $29.38 | ★ $76.75 |
| AVG Volume (30 Days) | ★ 2.3M | 674.1K |
| Earning Date | 10-28-2025 | 02-11-2026 |
| Dividend Yield | N/A | ★ 1.42% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.68 |
| Revenue | $240,000,000.00 | ★ $1,578,900,000.00 |
| Revenue This Year | N/A | $10.77 |
| Revenue Next Year | N/A | $6.74 |
| P/E Ratio | ★ N/A | $17.91 |
| Revenue Growth | N/A | ★ 9.30 |
| 52 Week Low | $6.50 | $41.54 |
| 52 Week High | $26.40 | $69.00 |
| Indicator | RCUS | CXT |
|---|---|---|
| Relative Strength Index (RSI) | 50.10 | 27.36 |
| Support Level | $21.80 | $46.02 |
| Resistance Level | $22.70 | $48.75 |
| Average True Range (ATR) | 1.27 | 1.85 |
| MACD | -0.45 | -0.52 |
| Stochastic Oscillator | 38.18 | 15.02 |
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
Crane NXT Co is a industrial technology company that provides proprietary and trusted technology solutions to secure, detect, and authenticate what matters to its customers. It is a pioneer in proprietary micro-optics technology for securing physical products, and its sophisticated electronic equipment and associated software leverages proprietary core capabilities with detection and sensing technologies. The company operates in two segments which are Crane Payment Innovations (CPI) and Security and Authentication Technologies.